New drug resistance, its preparation procedures, drug preparation containing drugs, and drug use

摘要

The invention relates to a formula indarkaoxamidas derivative, wherein R0 is C1-C4 hydrogen or tar; R1 is hydrogen, halide, etc.; R2 is hydrogen, C1-C6 tar or C1-C6 cyclopropylsulfonyl; W is pyridine, pyridan, etc.; R13 is C1-C6 hydrogen or tar; n is 0 or 1. The most popular compounds are n - {2 - [2 - (4 - [2 - [2 - (4-benzoilpiperazin-1-il) - 2-oxyetil] - 6-meth-2h-indazol-5-il} - 6 - (trifluoromethyl) pyridine-2-carboxamida; 6-ethyl-n - (6-methyl-2 - {2-oxo-2 [4 - (pirrolidin-1-il) piperidin-1-il) ethyl} - 2h-indal-pireidin-5; and other substances. These compounds are inhibitors in Iraq.Play a role in the treatment and / or prevention of diffuse and flammable diseases such as flammable skin diseases, lung diseases, autoimmune diseases